Word: symmetrel
(lookup in dictionary)
(lookup stats)
Dates: during 1970-1979
Sort By: most recent first
(reverse)
...long dreamed of producing "another nylon," but the company has introduced few notably profitable products in the past decade. Several that did appear turned out to be expensive failures. Corfam, the synthetic leather, is being phased out after an investment of $100 million. Other disappointments: an antiflu pill called Symmetrel and a venture into the production of photo film. Last week the board announced a decline in earnings from $93 million in the first quarter of 1970 to $74 million in the equivalent period this year...
...company has spent generously on drug research for two decades, but its first really promising product, an oral flu-preventive pill called Symmetrel, has been a commercial flop since it was introduced in 1967. Reason: Du Pont lacked both expertise and a sales force for drug marketing, and one result was that doctors generally did not prescribe it. Corfam, the first synthetic leather to "breathe," cost $60 million to get into production in 1964, but quick and stiff competition has made it only barely profitable. Du Pont is now improving the versatility of Corfam-in order to expand...